Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia

NCT01460160 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Pediatric

Interventions

DRUG: Dasatinib

Sponsor

Bristol-Myers Squibb

Collaborators

[object Object]
[object Object]